Efficacy of Structured Progressive Training Exercise on Muscle Strength of Patients With Rheumatoid Arthritis
Official Summary
This study aims to find out if a specific exercise program helps patients with Rheumatoid Arthritis (RA). RA is a chronic autoimmune disease that causes pain, weakness, and reduced function in the joints and muscles. While medication is common, exercise is also important for management. The study will test a program called "Progressive Resistance Training." About 118 adult patients with RA at AL-Najaf Teaching Hospital will participate. They will be divided into two groups. One group will perform specific resistance exercises for six weeks, while the other group will continue their usual care without this specific training. The researchers will measure muscle strength, cardiovascular function, and energy levels before and after the six-week program. The goal is to determine if this exercise improves muscle strength and helps patients perform daily activities more efficiently. The study hopes to show that resistance training is a safe and effective way to improve quality of life for people with RA.
Study Design
- Study Type: INTERVENTIONAL
- Allocation: NON_RANDOMIZED
- Model: PARALLEL
- Masking: SINGLE
- Enrollment: 118 participants
Interventions
- OTHER: Progressive Resistance Training — Progressive Resistance Training (PRT) program for patients with Rheumatoid Arthritis. The intervention consists of supervised resistance exercises targeting major muscle groups of upper and lower extremities. Program Details: * Duration: 6 weeks * Frequency: 3 sessions per week * Session duration: 45-60 minutes * Setting: AL-Najaf Teaching Hospital Exercise Components: * Warm-up exercises (10 minutes) * Resistance training using resistance bands, light weights, and body weight exercises (30-
Primary Outcomes
- Change in Muscle Strength from Baseline to 6 Weeks (Baseline and 6 weeks post-intervention)
More Rheumatoid Arthritis (RA) Trials
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.